Payment overview · 2025
General Payments
$127.42
1 reported records · 1 companies
Healthcare provider profile · identity verified
Michael Creppy, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · BERLIN, NH · NPI 1366859274
Verified facts
What the public records show
CMS Open Payments records show Michael Creppy, M.D. received $127.42 in general payments during 2025 across 1 reported records.
Edwards Lifesciences Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Edwards Lifesciences Corporation | Unresolved — no canonical attribution shown | $127.42 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $127.42 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| SAPIEN 3 Ultra RESILIA Normalized: sapien 3 ultra resilia |
Device | Edwards Lifesciences Corporation | $127.42 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 495 | 117 |
| Amlodipine Besylate | Amlodipine Besylate | 370 | 80 |
| Furosemide | Furosemide | 329 | 61 |
| Levothyroxine Sodium | Levothyroxine Sodium | 323 | 55 |
| Lisinopril | Lisinopril | 322 | 85 |
| Losartan Potassium | Losartan Potassium | 306 | 69 |
| Omeprazole | Omeprazole | 254 | 69 |
| Metoprolol Tartrate | Metoprolol Tartrate | 244 | 49 |
| Eliquis | Apixaban | 223 | 33 |
| Pantoprazole Sodium | Pantoprazole Sodium | 221 | 41 |
| Gabapentin | Gabapentin | 211 | 43 |
| Metformin Hcl | Metformin Hcl | 211 | 50 |
| Metoprolol Succinate | Metoprolol Succinate | 190 | 43 |
| Tamsulosin Hcl | Tamsulosin Hcl | 176 | 36 |
| Hydrochlorothiazide | Hydrochlorothiazide | 175 | 43 |
| Potassium Chloride | Potassium Chloride | 168 | 36 |
| Warfarin Sodium | Warfarin Sodium | 141 | 20 |
| Prednisone | Prednisone | 137 | 57 |
| Allopurinol | Allopurinol | 117 | 24 |
| Ozempic | Semaglutide | 108 | 21 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 105 | 19 |
| Escitalopram Oxalate | Escitalopram Oxalate | 104 | 22 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 98 | 30 |
| Trazodone Hcl | Trazodone Hcl | 94 | 17 |
| Simvastatin | Simvastatin | 93 | 28 |
| Lovastatin | Lovastatin | 89 | 22 |
| Montelukast Sodium | Montelukast Sodium | 89 | 16 |
| Jardiance | Empagliflozin | 84 | 19 |
| Spironolactone | Spironolactone | 84 | 16 |
| Sertraline Hcl | Sertraline Hcl | 83 | 16 |
| Pravastatin Sodium | Pravastatin Sodium | 78 | 27 |
| Tramadol Hcl | Tramadol Hcl | 78 | 27 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 75 | 32 |
| Cephalexin | Cephalexin | 75 | 40 |
| Levetiracetam | Levetiracetam | 73 | suppressed |
| Atenolol | Atenolol | 72 | 19 |
| Zolpidem Tartrate | Zolpidem Tartrate | 71 | 17 |
| Alprazolam | Alprazolam | 70 | 19 |
| Glipizide | Glipizide | 70 | 13 |
| Famotidine | Famotidine | 68 | 19 |
| Alendronate Sodium | Alendronate Sodium | 67 | 11 |
| Clopidogrel | Clopidogrel Bisulfate | 64 | suppressed |
| Carvedilol | Carvedilol | 62 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 59 | 11 |
| Duloxetine Hcl | Duloxetine Hcl | 59 | 16 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 59 | 15 |
| Breo Ellipta | Fluticasone/Vilanterol | 58 | 12 |
| Citalopram Hbr | Citalopram Hydrobromide | 54 | 14 |
| Divalproex Sodium | Divalproex Sodium | 51 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 50 | 16 |
| Lorazepam | Lorazepam | 49 | 17 |
| Metformin Hcl Er | Metformin Hcl | 49 | 12 |
| Topiramate | Topiramate | 49 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 49 | 24 |
| Clonazepam | Clonazepam | 48 | 11 |
| Memantine Hcl | Memantine Hcl | 46 | 13 |
| Fluticasone Propionate | Fluticasone Propionate | 45 | 12 |
| Meclizine Hcl | Meclizine Hcl | 44 | 15 |
| Amitriptyline Hcl | Amitriptyline Hcl | 43 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 43 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 41 | 12 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 38 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 37 | 26 |
| Buspirone Hcl | Buspirone Hcl | 36 | suppressed |
| Olanzapine | Olanzapine | 36 | suppressed |
| Finasteride | Finasteride | 35 | suppressed |
| Mirtazapine | Mirtazapine | 35 | 12 |
| Azithromycin | Azithromycin | 33 | 27 |
| Digoxin | Digoxin | 33 | suppressed |
| Metolazone | Metolazone | 32 | suppressed |
| Januvia | Sitagliptin Phosphate | 31 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 29 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 29 | 12 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 28 | 20 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 28 | suppressed |
| Ondansetron Odt | Ondansetron | 28 | suppressed |
| Pregabalin | Pregabalin | 28 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 27 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 27 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 27 | suppressed |
| Latanoprost | Latanoprost | 26 | suppressed |
| Trulicity | Dulaglutide | 26 | suppressed |
| Aripiprazole | Aripiprazole | 24 | suppressed |
| Baclofen | Baclofen | 24 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 24 | suppressed |
| Ezetimibe | Ezetimibe | 24 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 24 | suppressed |
| Nitroglycerin | Nitroglycerin | 24 | 19 |
| Xarelto | Rivaroxaban | 24 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 23 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 23 | suppressed |
| Synthroid | Levothyroxine Sodium | 23 | suppressed |
| Bupropion Xl | Bupropion Hcl | 22 | suppressed |
| Fluconazole | Fluconazole | 22 | 17 |
| Glipizide Er | Glipizide | 22 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 22 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 21 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 21 | suppressed |
| Celecoxib | Celecoxib | 21 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 21 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 21 | suppressed |
| Fenofibrate | Fenofibrate | 21 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 21 | suppressed |
| Lamotrigine | Lamotrigine | 21 | suppressed |
| Methylprednisolone | Methylprednisolone | 21 | 20 |
| Nystatin | Nystatin | 21 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 21 | suppressed |
| Triazolam | Triazolam | 21 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 20 | 16 |
| Spiriva Respimat | Tiotropium Bromide | 20 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 19 | suppressed |
| Fentanyl | Fentanyl | 19 | 11 |
| Irbesartan | Irbesartan | 19 | suppressed |
| Ketoconazole | Ketoconazole | 19 | 14 |
| Myrbetriq | Mirabegron | 19 | suppressed |
| Torsemide | Torsemide | 19 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 18 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 18 | suppressed |
| Mounjaro | Tirzepatide | 18 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 17 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 17 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 17 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 17 | suppressed |
| Sucralfate | Sucralfate | 17 | suppressed |
| Valsartan | Valsartan | 17 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Embrace Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Lansoprazole | Lansoprazole | 16 | suppressed |
| Linzess | Linaclotide | 16 | suppressed |
| Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 15 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 15 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 15 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 15 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 15 | suppressed |
| Klayesta | Nystatin | 15 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 15 | suppressed |
| Bumetanide | Bumetanide | 14 | suppressed |
| Humalog | Insulin Lispro | 14 | suppressed |
| Roflumilast | Roflumilast | 14 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 14 | suppressed |
| Acyclovir | Acyclovir | 13 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 13 | suppressed |
| Diazepam | Diazepam | 13 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 13 | suppressed |
| Ibuprofen | Ibuprofen | 13 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 13 | suppressed |
| Meloxicam | Meloxicam | 13 | suppressed |
| Novolog Flexpen | Insulin Aspart | 13 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 13 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 13 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 13 | suppressed |
| Mupirocin | Mupirocin | 12 | suppressed |
| Nadolol | Nadolol | 12 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 12 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Anastrozole | Anastrozole | 11 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 11 | suppressed |
| Hydroxyurea | Hydroxyurea | 11 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 11 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 11 | suppressed |
| Primidone | Primidone | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $127.42 · 1 records | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error